Dr. Simon Hsu, Chief Technology Officer and Senior Vice President, holds PhD degree from Purdue✱ University in Biochemical Engineering, Master degree from Ohio State University in Biochemical Engineering, and Bachelor degree from National ꦯTsing Hua University in Chemical Engineering.Dr. Simon Hsu hasover 28years of management and research experience in the pharmaceutical industry. He has directed and successfully managed more than 25antibodyandrecombinant proteinprojectsoftechnology transfer, scale-up and process validationup to 40,000L.Prior to joining Henlius,heserved forleading enterprise in pharmaceuticals industry, such asGenSci, HuiGene Therapeutics, Henlius, Pieris, Shire,Bristol-Myers Squibb,MedImmune(AstraZeneca), Alexion(AstraZeneca),etc. Dr. Simon Hsuhas extensive experience and technologyin process development, production, qualitycontrol, project management, international registration, licensing applications, clinical to market commercialization, and continuousbioprocess etc.